Literature DB >> 3915012

Clinical and microbiological evaluation of therapy for juvenile periodontitis.

K S Kornman, P B Robertson.   

Abstract

Eight patients (mean age 15.6 yrs) with severe molar-incisor bone loss and pocket formation characteristic of juvenile periodontitis were entered into a clinical protocol of three sequential stages: scaling and root planing (S/RP); S/RP concurrent with systemic tetracycline therapy (1 gm/day for 28 days); periodontal surgery concurrent with systemic tetracycline therapy. Clinical and microbiological examinations were scheduled at baseline, at 1 to 2 months after Stage I, at 1 to 2 months after completion of tetracycline therapy in Stages II and III, and during recall. A decision to progress to the next stage or to place the patient on a 3-month recall was based solely on clinical findings (suppuration, bleeding upon probing and pocket depth) at the deepest site in each patient. Paperpoint subgingival plaque samples from representative affected sites were analyzed for percentage of total cultivable microflora composed of black-pigmented Bacteroides species (BPB), surface translocating bacteria (STB) and Actinobacillus actinomycetemcomitans (Aa). At baseline, all sites bled to probing, seven of eight sites showed suppuration, and deepest pocket depths averaged 8.0 mm. STB were detected in one and BPB in four sites, respectively, and all sites demonstrated Aa, which constituted approximately 40% of the total cultivable flora. S/RP alone had essentially no effect on either clinical or microbiological findings, and all patients progressed to Stage II. Five went on to Stage III. S/RP with tetracycline was clinically and microbiologically more effective at sites in which Aa was predominant. Surgery was required in all sites containing high levels of both BPB and Aa. These results suggest that microbiological diagnosis may be useful in selecting and monitoring treatment for juvenile periodontitis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3915012     DOI: 10.1902/jop.1985.56.8.443

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  13 in total

1.  Improved, low-cost selective culture medium for Actinobacillus actinomycetemcomitans.

Authors:  M Alsina; E Olle; J Frias
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

2.  The role of Actinobacillus actinomycetemcomitans in periodontal disease.

Authors:  J de Graaff; A J van Winkelhoff; R J Goené
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

3.  Titer and subclass distribution of serum IgG antibody reactive with Actinobacillus actinomycetemcomitans in localized juvenile periodontitis.

Authors:  T Y Ling; T J Sims; H A Chen; C W Whitney; B J Moncla; L D Engel; R C Page
Journal:  J Clin Immunol       Date:  1993-03       Impact factor: 8.317

4.  Serum antibody in Actinobacillus actinomycetemcomitans-infected patients with periodontal disease.

Authors:  J L Ebersole; M N Sandoval; M J Steffen; D Cappelli
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

5.  Detection of subgingival periodontal pathogens--comparison of two sampling strategies.

Authors:  Katrin Nickles; Susanne Scharf; Lasse Röllke; Irina Mayer; Matthias Mayer; Peter Eickholz
Journal:  Clin Oral Investig       Date:  2015-07-21       Impact factor: 3.573

Review 6.  Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis.

Authors:  B A Herbert; C M Novince; K L Kirkwood
Journal:  Mol Oral Microbiol       Date:  2015-09-22       Impact factor: 3.563

7.  Systemic and mucosal immune responses in mice orally immunized with avirulent Salmonella typhimurium expressing a cloned Porphyromonas gingivalis hemagglutinin.

Authors:  D M Dusek; A Progulske-Fox; T A Brown
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

8.  Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high-responder patients.

Authors:  J V Califano; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

9.  Immunoglobulin class and subclass distribution of antibodies reactive with the immunodominant antigen of Actinobacillus actinomycetemcomitans serotype b.

Authors:  H Lu; J V Califano; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

10.  Systemic anti-microbial agents used in periodontal therapy.

Authors:  Vishakha Patil; Rohini Mali; Amita Mali
Journal:  J Indian Soc Periodontol       Date:  2013-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.